ArticleFrontiers in pediatrics2025
Age-stratified reference ranges for adenoid hypertrophy in children: a single-center retrospective study.
Article in Frontiers in pediatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Growth and sleep outcomes after adenotonsillectomy in pediatric mild sleep-disordered breathing.Scientific reports · 2025Trial
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Adenoid hypertrophy (AH) is prevalent in 35%-70% of the global pediatric population, leading to airway obstruction and sleep disturbances. Current diagnostic criteria for the adenoid-to-nasopharyngeal ( Methods: This retrospective study assessed pediatric outpatients aged 1-12 years who underwent lateral nasopharyngeal radiography. Measurements of adenoid depth (AD), nasopharyngeal depth (ND), and Results: In this investigation involving 2,629 outpatient children aged between 1 and 12 years, the median AD remained consistent at 14-15 mm, whereas ND increased from 21 to 27 mm, resulting in a decrease in the Conclusions: This study established percentile-based reference values (P5-P95) for AD, ND, and the
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.